Bakeries are scrambling to reformulate with aquafaba, flaxseed or chia just as GLP-1 demand accelerates protein consumption
Spotlight on Featured content 86% of cancers aren't caught by recommended screenings
Various systemic diseases, including cancer, renal failure, chronic obstructive pulmonary disease, sepsis and trauma, also accelerate sarcopenia progression (66)
Heres the good news: Semaglutide (Wegovy, Ozempic), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda) are NOT controlled substances
And everyone deserves the chance to feel at peace in their own body, like I finally do
It affects roughly 10 to 20% of children and up to 10% of adults globally, and its prevalence has been rising alongside rates of obesity and metabolic dysfunction